Annual SG&A
$4.51 M
-$976.30 K-17.79%
01 December 2023
Summary:
Revelation Biosciences annual selling, general & administrative expenses is currently $4.51 million, with the most recent change of -$976.30 thousand (-17.79%) on 01 December 2023. REVB annual SG&A is now -87.59% below its all-time high of $36.34 million, reached on 01 December 2019.REVB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$965.70 K
-$161.80 K-14.35%
01 September 2024
Summary:
Revelation Biosciences quarterly selling, general & administrative expenses is currently $965.70 thousand, with the most recent change of -$161.80 thousand (-14.35%) on 01 September 2024. Over the past year, it has dropped by -$300.20 thousand (-23.71%). REVB quarterly SG&A is now -66.77% below its all-time high of $2.91 million, reached on 31 March 2022.REVB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$128.93 M
-$15.52 M-13.68%
01 September 2024
Summary:
Revelation Biosciences TTM selling, general & administrative expenses is currently -$128.93 million, with the most recent change of -$15.52 million (-13.68%) on 01 September 2024. Over the past year, it has dropped by -$133.44 million (-2958.34%). REVB TTM SG&A is now -1109.86% below its all-time high of $6.89 million, reached on 31 March 2022.REVB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -23.7% | -2958.3% |
| 3 y3 years | - | -36.1% | -3453.9% |
| 5 y5 years | -87.6% | - | - |
REVB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -17.8% | at low | -66.8% | +18.1% | -1109.9% | at low |
| 5 y | 5 years | -87.6% | at low | -66.8% | +18.1% | -1109.9% | at low |
| alltime | all time | -87.6% | at low | -66.8% | +18.1% | -1109.9% | at low |
Revelation Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $965.70 K(-14.4%) | $4.54 M(-3.4%) |
| June 2024 | - | $1.13 M(-4.8%) | $4.70 M(+2.3%) |
| Mar 2024 | - | $1.18 M(-6.4%) | $4.60 M(+2.0%) |
| Dec 2023 | $4.51 M(-17.8%) | $1.27 M(+12.4%) | $4.51 M(+9.4%) |
| Sept 2023 | - | $1.13 M(+10.0%) | $4.12 M(+8.1%) |
| June 2023 | - | $1.02 M(-6.5%) | $3.81 M(+3.8%) |
| Mar 2023 | - | $1.09 M(+24.6%) | $3.68 M(-33.0%) |
| Dec 2022 | $5.49 M | $878.40 K(+7.4%) | $5.49 M(-5.4%) |
| Sept 2022 | - | $817.90 K(-7.6%) | $5.80 M(-10.7%) |
| June 2022 | - | $884.80 K(-69.6%) | $6.49 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $2.91 M(+143.9%) | $6.89 M(+36.8%) |
| Dec 2021 | $5.04 M(-86.1%) | $1.19 M(-21.2%) | $5.04 M(+31.0%) |
| Sept 2021 | - | $1.51 M(+17.8%) | $3.84 M(+64.8%) |
| June 2021 | - | $1.28 M(+22.1%) | $2.33 M(+122.1%) |
| Mar 2021 | - | $1.05 M | $1.05 M |
| Dec 2019 | $36.34 M(+6.9%) | - | - |
| Dec 2018 | $33.98 M(+8.9%) | - | - |
| Dec 2017 | $31.20 M(+45.2%) | - | - |
| Dec 2016 | $21.49 M(+60.2%) | - | - |
| Dec 2015 | $13.41 M | - | - |
FAQ
- What is Revelation Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Revelation Biosciences?
- What is Revelation Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Revelation Biosciences?
- What is Revelation Biosciences quarterly SG&A year-on-year change?
- What is Revelation Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Revelation Biosciences?
- What is Revelation Biosciences TTM SG&A year-on-year change?
What is Revelation Biosciences annual selling, general & administrative expenses?
The current annual SG&A of REVB is $4.51 M
What is the all time high annual SG&A for Revelation Biosciences?
Revelation Biosciences all-time high annual selling, general & administrative expenses is $36.34 M
What is Revelation Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of REVB is $965.70 K
What is the all time high quarterly SG&A for Revelation Biosciences?
Revelation Biosciences all-time high quarterly selling, general & administrative expenses is $2.91 M
What is Revelation Biosciences quarterly SG&A year-on-year change?
Over the past year, REVB quarterly selling, general & administrative expenses has changed by -$300.20 K (-23.71%)
What is Revelation Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of REVB is -$128.93 M
What is the all time high TTM SG&A for Revelation Biosciences?
Revelation Biosciences all-time high TTM selling, general & administrative expenses is $6.89 M
What is Revelation Biosciences TTM SG&A year-on-year change?
Over the past year, REVB TTM selling, general & administrative expenses has changed by -$133.44 M (-2958.34%)